Outcomes cancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy9

Cell Line, Tumor Neoplastic Stem Cells Breast Prostate Tumor Cells, Cultured HCT116 Cells MCF-7 Cells HT29 Cells Lymph Nodes

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases49

Prostatic Neoplasms Breast Neoplasms Ovarian Neoplasms Lung Neoplasms Stomach Neoplasms Colonic Neoplasms Neoplasm Metastasis Neoplasms Neoplasm Invasiveness Pancreatic Neoplasms Disease Progression Uterine Cervical Neoplasms Genetic Predisposition to Disease Carcinoma, Squamous Cell Carcinoma Neoplasm Recurrence, Local Carcinoma, Non-Small-Cell Lung Colorectal Neoplasms Urinary Bladder Neoplasms Rectal Neoplasms Endometrial Neoplasms Cell Transformation, Neoplastic Esophageal Neoplasms Recurrence Liver Neoplasms Adenocarcinoma Postoperative Complications Head and Neck Neoplasms Bone Neoplasms Mouth Neoplasms Neoplasms, Hormone-Dependent Neoplasms, Second Primary Neoplasms, Glandular and Epithelial Neoplasms, Radiation-Induced Carcinoma, Small Cell Skin Neoplasms Neovascularization, Pathologic Genital Neoplasms, Female Gastrointestinal Neoplasms Precancerous Conditions Thyroid Neoplasms Disease Models, Animal Kidney Neoplasms Mammary Neoplasms, Experimental Melanoma Neoplasms, Multiple Primary Stroke Pharyngeal Neoplasms Occupational Diseases

Chemicals and Drugs43

Cancer Vaccines Neoplasm Proteins Antineoplastic Agents Tumor Markers, Biological Receptors, Estrogen RNA, Messenger Receptor, erbB-2 Prostate-Specific Antigen DNA, Neoplasm Fluorouracil RNA, Small Interfering Tumor Suppressor Protein p53 Tamoxifen Cisplatin Antineoplastic Agents, Hormonal Receptors, Progesterone Antigens, Neoplasm Paclitaxel Antineoplastic Agents, Phytogenic Antibodies, Monoclonal Anticarcinogenic Agents Receptor, Epidermal Growth Factor MicroRNAs Tumor Suppressor Proteins Deoxycytidine Antibodies, Monoclonal, Humanized Antimetabolites, Antineoplastic Taxoids DNA-Binding Proteins Biological Markers RNA, Neoplasm Receptors, Androgen Proto-Oncogene Proteins BRCA2 Protein Transcription Factors Nuclear Proteins Androgens Estrogens BRCA1 Protein Protein Kinase Inhibitors Proto-Oncogene Proteins c-akt Carcinogens Androgen Antagonists

Analytical, Diagnostic and Therapeutic Techniques and Equipment87

Treatment Outcome Early Detection of Cancer Retrospective Studies Follow-Up Studies Pregnancy Outcome Prognosis Prospective Studies Survival Analysis Survival Rate Risk Factors Risk Assessment Registries Antineoplastic Combined Chemotherapy Protocols Kaplan-Meier Estimate Multivariate Analysis Risk Predictive Value of Tests Neoplasm Staging Combined Modality Therapy Odds Ratio Cohort Studies Logistic Models Gene Expression Profiling Reverse Transcriptase Polymerase Chain Reaction Sensitivity and Specificity Xenograft Model Antitumor Assays Reproducibility of Results Chemotherapy, Adjuvant Incidence Clinical Trials as Topic Blotting, Western Neoplasm Transplantation Disease-Free Survival Severity of Illness Index Confidence Intervals Oligonucleotide Array Sequence Analysis Transplantation, Heterologous Chi-Square Distribution Mammography Research Design Tumor Burden SEER Program Polymerase Chain Reaction Regression Analysis Radiotherapy Molecular Targeted Therapy Drug Screening Assays, Antitumor Pilot Projects Neoplasm Grading Questionnaires Models, Biological Patient Selection Tomography, X-Ray Computed Tissue Array Analysis Biopsy Transfection Palliative Care Analysis of Variance Glasgow Outcome Scale Cross-Sectional Studies Prevalence Longitudinal Studies Feasibility Studies Radiotherapy, Adjuvant Immunohistochemistry Flow Cytometry Randomized Controlled Trials as Topic Immunoenzyme Techniques Prostatectomy Disease Models, Animal Statistics, Nonparametric Mastectomy Length of Stay Double-Blind Method Gene Knockdown Techniques Genetic Testing Probability Mammary Neoplasms, Experimental ROC Curve Immunotherapy Models, Statistical DNA Mutational Analysis Drug Administration Schedule Radiotherapy Dosage Colonoscopy Treatment Failure Drug Delivery Systems

Psychiatry and Psychology1

Phenomena and Processes44

Pregnancy Outcome Gene Expression Regulation, Neoplastic Time Factors Risk Genetic Predisposition to Disease Odds Ratio Drug Resistance, Neoplasm Mutation Sensitivity and Specificity Pregnancy Genotype DNA Methylation Cell Survival Dose-Response Relationship, Drug Chi-Square Distribution Polymorphism, Genetic Down-Regulation Cell Movement Genes, BRCA1 Apoptosis Cell Proliferation Cell Division Cell Cycle Promoter Regions, Genetic Cell Growth Processes Up-Regulation RNA Interference Diet Transfection Phenotype Gene Silencing Genes, Tumor Suppressor Genes, Neoplasm Germ-Line Mutation Postmenopause Genes, p53 Gene Expression Signal Transduction Base Sequence Genes, BRCA2 Probability Alleles Recovery of Function Phosphorylation

Disciplines and Occupations4

Outcome Assessment (Health Care)Research Design Medical Oncology Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena4

Quality of Life National Cancer Institute (U.S.)Age Distribution Socioeconomic Factors

Humanities1

Quality of Life

Information Science9

Survival Rate Registries Incidence SEER Program Questionnaires Glasgow Outcome Scale Prevalence Base Sequence Molecular Sequence Data

Named Groups3

Survivors Infant, Newborn African Americans

Health Care57

Treatment Outcome Outcome Assessment (Health Care)Retrospective Studies Follow-Up Studies Prospective Studies Survival Analysis Survival Rate Risk Factors Risk Assessment Registries Age Factors Kaplan-Meier Estimate Multivariate Analysis Risk Predictive Value of Tests Outcome and Process Assessment (Health Care)Odds Ratio Cohort Studies Logistic Models National Cancer Institute (U.S.)Sensitivity and Specificity Reproducibility of Results Incidence Clinical Trials as Topic Disease-Free Survival Severity of Illness Index Confidence Intervals Chi-Square Distribution SEER Program Regression Analysis Sex Factors Pilot Projects Questionnaires Patient Selection American Cancer Society Age Distribution Palliative Care Analysis of Variance Glasgow Outcome Scale Cross-Sectional Studies Prevalence Patient Satisfaction Cost-Benefit Analysis Longitudinal Studies Feasibility Studies Randomized Controlled Trials as Topic Statistics, Nonparametric Socioeconomic Factors Length of Stay Double-Blind Method Confounding Factors (Epidemiology)Genetic Testing Probability Patient Outcome Assessment ROC Curve Models, Statistical Treatment Failure

Geographicals7

United States Japan China Great Britain Sweden Europe England

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Treatment Outcome Outcome Assessment (Health Care)Early Detection of Cancer Retrospective Studies Follow-Up Studies Pregnancy Outcome Prognosis Prospective Studies Prostatic Neoplasms Breast Neoplasms Ovarian Neoplasms Lung Neoplasms Survival Analysis Survival Rate Stomach Neoplasms Colonic Neoplasms Neoplasm Metastasis Neoplasms Risk Factors Neoplasm Invasiveness Risk Assessment United States Pancreatic Neoplasms Gene Expression Regulation, Neoplastic Disease Progression Registries Time Factors Mice, Nude Cancer Vaccines Age Factors Neoplasm Proteins Antineoplastic Combined Chemotherapy Protocols Kaplan-Meier Estimate Multivariate Analysis Risk Predictive Value of Tests Antineoplastic Agents Outcome and Process Assessment (Health Care)Neoplasm Staging Uterine Cervical Neoplasms Genetic Predisposition to Disease Combined Modality Therapy Odds Ratio Tumor Markers, Biological Cohort Studies Carcinoma, Squamous Cell Logistic Models Carcinoma Quality of Life Neoplasm Recurrence, Local Carcinoma, Non-Small-Cell Lung Drug Resistance, Neoplasm Colorectal Neoplasms Gene Expression Profiling Urinary Bladder Neoplasms Survivors Reverse Transcriptase Polymerase Chain Reaction Cell Line, Tumor National Cancer Institute (U.S.)Receptors, Estrogen Mutation Sensitivity and Specificity RNA, Messenger Xenograft Model Antitumor Assays Receptor, erbB-2 Rectal Neoplasms Smoking Reproducibility of Results Pregnancy Chemotherapy, Adjuvant Incidence Clinical Trials as Topic Prostate-Specific Antigen Genotype Infant, Newborn DNA, Neoplasm Endometrial Neoplasms Blotting, Western Neoplasm Transplantation Cell Transformation, Neoplastic Esophageal Neoplasms DNA Methylation Disease-Free Survival Fluorouracil RNA, Small Interfering Tumor Suppressor Protein p53 Severity of Illness Index Tamoxifen Recurrence Cell Survival Cisplatin Confidence Intervals Liver Neoplasms Adenocarcinoma Postoperative Complications Antineoplastic Agents, Hormonal Dose-Response Relationship, Drug Oligonucleotide Array Sequence Analysis Receptors, Progesterone Transplantation, Heterologous

No FAQ available that match "outcomes cancer"